Medical News

ETView’s VivaSight Products Highlighted in Anesthesiology News

date 28-September-2014
ETView’s VivaSight Products Highlighted in Anesthesiology News

ETView’s VivaSight visualization and monitoring devices were highlighted in this article in Anesthesiology News.

MediValve Announces Post-Market Clinical Evaluations

MediValve Announces Post-Market Clinical Evaluations

MediValve announced it successfully completed the first two cases of post-market clinical evaluation of its acWire Guidewire for use in peripheral vascular and heart catheterization procedures.

The Trendlines Group Update September 2014

The Trendlines Group Update September 2014

… Steve Rhodes on tech development … 4 companies on Israel 21c list … ETView exhibits at conferences … “Startup lessons” includes Trendlines Agtech … Spotlight shines on EdenShield …

EnzySurge, Gordian, IonMed, and LifeBond among Top Israel Wound-Care Innovations

date 04-September-2014
EnzySurge, Gordian, IonMed, and LifeBond among Top Israel Wound-Care Innovations

Four of our medical portfolio companies appear on ISRAEL 21c’s list of “11 top Israeli wound-care innovations.”

Start-Ups at the Forefront of Technological Development

Start-Ups at the Forefront of Technological Development

Steve Rhodes, CEO & Chairman of The Trendlines Group, shares his views on the role of Israeli technological developments in Industry, a Hebrew-language magazine.

The Trendlines Group Update August 2014

The Trendlines Group Update August 2014

… Trendlines’ founders receive honor … Welcome to Vensica … Healthfundr Insight interviews Omer Schalit-Cohen … Valentis signs MOU … Agri Investor features Nitza Kardish …

Omer Schalit-Cohen Interview Appears in Healthfundr Insights

Omer Schalit-Cohen Interview Appears in Healthfundr Insights

Omer Schalit-Cohen, VP, Business Developments, Trendines Medical, addresses capital efficiency, milestones, outsourcing, and more in this Q&A with Healthfundr Insights.

The Trendlines Group Update July 2014

The Trendlines Group Update July 2014

… Trendlines Acquires IP from Endo … NovoSpeech Receives U.S. Patent … ETView Receives Investment … Catalyst AgTech Appears on Canadian TV … Companies Raising Money …

Endobetix Featured as Globes’ Start-Up of the Week

Endobetix Featured as Globes’ Start-Up of the Week

The Endobetix device diverts bile in the intestine, lowering blood sugar and preventing the need for risky gastric bypass surgery.

ETView Reports on Two Clinical Evaluations of VivaSight™

ETView Reports on Two Clinical Evaluations of VivaSight™

ETView announces two clinical reports on the use of its VivaSight™ to achieve single lung isolation.

Trendlines Medical Featured in MIXiii BioMed Article

Trendlines Medical Featured in MIXiii BioMed Article

Trendlines Medical featured prominently in this recap of MIXiii | BioMed on the Israel Ministry of Foreign Affairs site.

Dune Medical Raises $21 Million

Dune Medical Raises $21 Million

The Kraft Group and Carnepa Advanced Healthcare led Dune Medical’s $21 million raise. Dune’s MarginProbe device use RF rays to make real-time diagnoses during breast cancer surgery.

Migdal Insurance and Private Investors To Invest in ETView

Migdal Insurance and Private Investors To Invest in ETView

ETView Medical signed an investment agreement with Migdal Insurance Company and a group of private investors in a NIS 7 million private placement.

Trendlines Featured in Times of Israel

Trendlines Featured in Times of Israel

Trendlines’ medical technology incubator was named the best incubator in Israel by the Office of the Chief Scientist (OCS). Two Trendlines’ portfolio companies — MitrAssist and Advanced Mem-Tech — were named best start-ups of the year by the OCS.

The Trendlines Group Update June 2014

The Trendlines Group Update June 2014

… Trendlines Scores a Hat Trick at OCS Awards … Steve Rhodes To Address Agri Investment Forum … NeuroQuest To Open U.S. Headquarters … Metabolic Robots’ Founder Honored …

Trendlines Scores a Hat Trick at Israel’s Chief Scientist Awards

Trendlines Scores a Hat Trick at Israel’s Chief Scientist Awards

Trendlines Medical and two portfolio companies of The Trendlines Group keep Trendlines on its award-winning path.

Can Israeli Medical Technology Lead the World?

Can Israeli Medical Technology Lead the World?

Interview with Todd Dollinger, Chairman and CEO of The Trendlines Group, in the Chinese publication, China Medical Personnel.

Trendlines Medical Exits

Trendlines Medical Exits

News about Trendlines Medical exits and acquisitions.

Inspiro Medical Acquired by OPKO Health

Inspiro Medical Acquired by OPKO Health

OPKO Health, a multinational biopharmaceutical and diagnostics company, acquired Inspiro Medical and its novel dry powder inhaler, Inspiromatic.

Analyst: ETView Stock “Worth Tracking”

Analyst: ETView Stock “Worth Tracking”

ETView picked as an “Israeli biomed stock worth tracking.”

The Trendlines Group Update May 2014

The Trendlines Group Update May 2014

… OPKO Acquires Inspiro … Gordian Completes $1 Million Raise … Joint Venture with China’s Anhui Luban … Nitza “Transforming Agritech” … Meet Us at MIXiii | Biomed …

Globes’ Start-Up of the Week: SensoGo

Globes’ Start-Up of the Week: SensoGo

SensoGo featured as Start-Up of the Week in Globes.

Omer Schalit-Cohen One of the Judges at TAU Innovation Day

Omer Schalit-Cohen One of the Judges at TAU Innovation Day

Trendlines Medical VP Bus Dev Omer Schalit-Cohen will be a judge in the TLV Start-Up Challenge, part of this year’s TAU Innovation Day, May 13.

Gordian Surgical Completes $1 Million Raise

Gordian Surgical Completes $1 Million Raise

Gordian Surgical recently completed a $1 million raise from angel investors, surgeons, and a private investment fund.

Trendlines To Establish Joint Venture with China’s Anhui Luban Construction Investment Group

Trendlines To Establish Joint Venture with China’s Anhui Luban Construction Investment Group

Trendlines and the Anhui Luban Construction Investment Group have agreed to establish an agritech incubator in Anhui Province, China.

Endobetix To Attend DDW®2014 in Chicago

Endobetix To Attend DDW®2014 in Chicago

Members of the Endobetix team will be in Chicago, Illinois, from May 3 to 6 to attend this year’s Digestive Disease Week®.

NeuroQuest To Establish Headquarters in United States

NeuroQuest To Establish Headquarters in United States

NeuroQuest will sign a lease to establish its headquarters in Charleston, South Carolina.

The Trendlines Group Update April 2014

The Trendlines Group Update April 2014

… Trendlines Labs and Sheba Medical Center agreement … Patent for NovoSpeech … Endobetix, NeuroQuest, and Sol Chip in media … Investment Event and Agrivest videos …

Omer Schalit-Cohen a Panelist at IN3 Dublin

Omer Schalit-Cohen a Panelist at IN3 Dublin

In Dublin on April 8? Catch Trendlines Medical’s Omer Schalit-Cohen on the medtech innovation panel at this year’s IN3 Medical Device 360.

Spotlight On: Novel Catheter for Treating Peripheral Vascular Disease

Spotlight On: Novel Catheter for Treating Peripheral Vascular Disease

Discover why doctors, investors, and medical device companies should keep their eyes on SiL Vascular.

Steve Rhodes a Panelist at iBIO IndEx

Steve Rhodes a Panelist at iBIO IndEx

Trendlines Chairman and CEO Steve Rhodes will participate on the international panel at this year’s iBIO IndEx, April 24 in Chicago, Illinois.

Study Supports the Endobetix Approach to T2D

Study Supports the Endobetix Approach to T2D

Endobetix advisor and SAB member Prof. Randy Seeley, who is quoted in this National Geographic article, explains the significance of the biochemical changes after bariatric surgery.

The Power of the Crowd

The Power of the Crowd

Trendlines Marcom Consultant Shira Zimmerman discovers the strength “of the crowd” in this article for The Times of Israel.

Trendlines Labs Signs Collaboration Agreement with Sheba Medical Center

Trendlines Labs Signs Collaboration Agreement with Sheba Medical Center

Trendlines Labs signed a collaboration agreement with Sheba Medical Center, the largest hospital in Israel and in the Middle East.

NeuroQuest’s Prof. Michal Schwartz Featured in Israel21c

NeuroQuest’s Prof. Michal Schwartz Featured in Israel21c

Prof. Michal Schwartz, scientific adviser to portfolio company NeuroQuest, was the subject of a feature story in Israel21c.

The Trendlines Group Update March 2014

The Trendlines Group Update March 2014

… Steve and Todd on Canadian TV … Collaboration for Trendlines Labs … … Now Funding … Agri Tech in China … FDA for MediValve … Collaboration for Sol Chip …

Eran Feldhay and Trendlines Medical Featured in G (Globes) Magazine

Eran Feldhay and Trendlines Medical Featured in G (Globes) Magazine

Eran Feldhay, CEO of Trendlines Medical, was featured in this look at Israeli technology incubators.

Steve Rhodes and Todd Dollinger on Canadian TV

Steve Rhodes and Todd Dollinger on Canadian TV

Steve Rhodes and Todd Dollinger appear on Canadian TV.

FDA and CE Clearance for MediValve

date 21-February-2014
FDA and CE Clearance for MediValve

MediValve announced it received clearance of a PMA (510(k)) from the U.S. FDA and European pre-market clearance for its acWire Guidewire, which is used during Transcatheter Aortic Valve Implantation (TAVI) procedures.

Todd Dollinger Quoted in Health Care Publication

Todd Dollinger Quoted in Health Care Publication

Trendlines Chairman and CEO Todd Dollinger was quoted in this German-language publication about health care.

Trendlines Signs Collaboration Agreement with Roper St. Francis

Trendlines Signs Collaboration Agreement with Roper St. Francis

Trendlines Labs signed an agreement for collaboration with Roper St. Francis Healthcare to collaborate on the development of new medical device inventions.

Immunovative Therapies To Conduct Clinical Trial of New Cancer Vaccine

date 15-January-2014
Immunovative Therapies To Conduct Clinical Trial of New Cancer Vaccine

Immunovative Therapies will be conducting a Phase I/II clinical trial of CRCL-AlloVax, a new cancer vaccine that “has potential activity against a wide variety of tumors.”

Spotlight On: Improved Closure Solution for Abdominal Incisions

date 12-January-2014
Spotlight On: Improved Closure Solution for Abdominal Incisions

Gordian Surgical, founded in 2012, is developing a novel, two-in-one trocar with a built-in closure device that offers physicians a simple, safe, and cost-saving approach for opening and suturing abdominal incisions. Zvi Peer, CEO of Gordian […]

The Trendlines Group Update January 2014

The Trendlines Group Update January 2014

… Join us in Israel for our 4th Annual Investment Event on Jan. 28, 2014 … Missed Agrivest? Watch it “live” … GreenSpense takes the “prizes” … Welcome 5 new companies! …

2013 Was a Multimillion-Dollar Year

2013 Was a Multimillion-Dollar Year

January. It’s that time again. A time to take one last look at Trendlines and our portfolio companies in 2013.

Say Goodbye to Surgical Stitches and Staples

date 26-December-2013
Say Goodbye to Surgical Stitches and Staples

IonMed’s cold plasma technology leads the way toward scar-free incision closure. This story was one of Israel21c’s most popular in 2013.

Spotlight On: A Novel Treatment For Type 2 Diabetes

Spotlight On: A Novel Treatment For Type 2 Diabetes

Endobetix, founded by Chen Porat and Pierre Shavit in August 2012, is developing a minimally invasive, nonsurgical implant to treat type 2 diabetes and obesity that mimics the hormonal benefits offered by bariatric surgery (reducing […]

NeuroQuest One of Top 10 Israeli Medical Advances to Watch in 2014

date 22-December-2013
NeuroQuest One of Top 10 Israeli Medical Advances to Watch in 2014

Congratulations to NeuroQuest, named one of the “10 most extraordinary medical devices and pharmaceuticals waiting in the wings to revolutionize global healthcare” by Israel21c.

Spotlight On: Safer Epidural Procedures

Spotlight On: Safer Epidural Procedures

Omeq Medical, founded by Lior Margalit and Oded Tsamir in April 2013, is developing a sensor-based epidural placement system for safe, accurate epidural injections. Their system will give automatic acoustic and visual signals to indicate […]

The Trendlines Group Update November 2013

The Trendlines Group Update November 2013

… Teleflex acquires medical portfolio company Innolap … ApiFix completes 2nd financing round … GreenSpense to represent Israel at Int’l Cleantech Competition … more news …

Calling the Crowd: Trendines Companies Ready for Investment

date 19-November-2013
Calling the Crowd: Trendines Companies Ready for Investment

For the first time ever, Trendlines joined with Our Crowd this fall to showcase four of our medical companies to investors in six U.S. cities.

LapSpace Medical Completes Raise

date 12-November-2013
LapSpace Medical Completes Raise

LapSpace Medical completed a raise by private investors, Trendlines, and Israel’s Office of the Chief Scientist.

Israeli Device Makes Abdominal Surgery Easier

date 29-October-2013
Israeli Device Makes Abdominal Surgery Easier

LapSpace Medical’s unique retractor makes laparoscopic surgery easier and less traumatic.

ApiFix Completes 2nd Financing Round

date 22-October-2013
ApiFix Completes 2nd Financing Round

Spinal implant company ApiFix closed a second financing round of several million dollars.

ApiFix and IonMed among the 12 Most Amazing Israeli Medical Advances

date 15-October-2013
ApiFix and IonMed among the 12 Most Amazing Israeli Medical Advances

Congratulations to portfolio companies ApiFix and IonMed. Israel21c chose their products as part of “the top 12 most amazing Israeli medical advances.”

Waiting for the Doctor? He’s Already Received Your Results

date 13-October-2013
Waiting for the Doctor? He’s Already Received Your Results

SensoGo’s unique device for gait analysis collects data while the patient waits to see the doctor.

Leviticus Cardio Completes NIS 4 Million Raise

date 13-October-2013
Leviticus Cardio Completes NIS 4 Million Raise

Israeli development makes life easier for cardiac patients

Chinese “Deal Accelerator” Puts the Spotlight on Trendlines

Chinese “Deal Accelerator” Puts the Spotlight on Trendlines

Trendlines Chairmen and CEOs presented 13 portfolio companies at the China-Israel Investment Symposium, which was sponsored by ZVCA, China’s largest technology hub.

InnoLap Surgical Microlaparoscopy Technology Acquired by Teleflex

date 01-October-2013
InnoLap Surgical Microlaparoscopy Technology Acquired by Teleflex

InnoLap, a Trendlines portfolio company established in mid-2012, identifies unmet need in minimally invasive procedures.

Trendlines Medical U.S. Road Show October 14-18

date 15-September-2013
Trendlines Medical U.S. Road Show October 14-18

We take periodic U.S. road shows to showcase our medical and agritech companies. Join us for our October events.

Baxter Buys Urine Monitoring Co FlowSense for $9.5m

date 10-September-2013
Baxter Buys Urine Monitoring Co FlowSense for $9.5m

The global healthcare company Baxter International (NYSE: BAX) acquired Trendlines portfolio company Flowsense Medical.

Omeq Medical in Globes

date 04-September-2013
Omeq Medical in Globes

Omeq Medical was named on the “6 captivating start-ups of the past year” by Globes.

IonMed Chairman Interviewed on Israeli TV

date 24-July-2013
IonMed Chairman Interviewed on Israeli TV

Yoav Avidor, IonMed’s chairman, explains the company’s cold plasma technology on the popular Israeli news show London & Kirshenbaum.

Trendlines Medical Q3 2013 Update

Trendlines Medical Q3 2013 Update

Trendlines Medical – Misgav Q3 2013 update

Globes’ Start-Up of the Week: CoreBone

date 13-July-2013
Globes’ Start-Up of the Week: CoreBone

When bone is missing, bone substitutes provide a very real scaffold. CoreBone’s coral-based bone graft substitute makes a very strong scaffold.

Italians Say “Si” to Israeli Biomed

date 09-July-2013
Italians Say “Si” to Israeli Biomed

Trendlines Medical and some of its companies were mentioned in this article about the 12th annual Biomed conference in Tel Aviv in June 2013.

MitrAssist Completes Raise of $1 Million

date 01-July-2013
MitrAssist Completes Raise of $1 Million

MitrAssist’s $1 million raise went beyond their initial target.

Trendlines Portfolio Companies Take Two “Best Start-up of the Year” Awards

Trendlines Portfolio Companies Take Two “Best Start-up of the Year” Awards

For the second year in a row, Trendlines portfolio companies have won “Best Start-up of the Year,” an award presented by the Office of the Chief Scientist in Israel.

Sol Chip and ApiFix Win 2013 Best Incubator Graduates

Sol Chip and ApiFix Win 2013 Best Incubator Graduates

Congratulations to Sol Chip and ApiFix. They were named “best technology incubator graduates” by Israel’s Technological Incubators Program.

LIKE from Breezy Relieves Bad Breath for at Least Four Hours

date 11-June-2013
LIKE from Breezy Relieves Bad Breath for at Least Four Hours

Breezy’s LIKE product relieves bad breath for hours. It appeared on shelves in more than 650 Israel pharmacies and supermarkets.

  • Welcome to Trendlines

    We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >

  • Categories

  • Subscribe to Our Newsletter

  • Stay in Touch

    icon-facebook Like us on Facebook

    icon-Twitter Follow us on Twitter

    icon-Linkedin Connect with us on Linkedin

    YouTube-color See us on YouTube

    flipboard  Read us on Flipboard

    google+_icon Join us on Google+